NuvaRing

PreclinicalSmall molecule

UUniversity of Washington

NuvaRing is one of 114 small molecule programs targeting Contraception. It is currently in Preclinical.

Indications

Total Trials

Active Trials

113

Competitors

Pipeline

Status by Indication[3][1]

Indication

ContraceptionActive, not recruiting

MenorrhagiaActive, not recruiting

AdolescentTerminated

TreatmentTerminated

OvarianCompleted

AcceptabilityCompleted

ContraceptionPreclinical

Active, not recruiting

MenorrhagiaPreclinical

Active, not recruiting

AdolescentPreclinical

Terminated

TreatmentPreclinical

Terminated

OvarianPreclinical

Completed

AcceptabilityPreclinical

Completed

Competition

Competitive Landscape

332 competitors in Treatment

#DrugCompanyPhaseTrials

Biltricide

Bayer

Preclinical

3 2

Alfenta

Jazz Pharmaceuticals

Preclinical

1 3

Niclocide

Bayer

Preclinical

1 4

Minipress

Pfizer

Preclinical

1 5

Theo-Dur

Pfizer

Preclinical

1 6

Intuniv

PPromius Pharma, LLC

Preclinical

1 7

Nerlynx

PPuma Biotechnology, Inc.

Preclinical

1 8

Clomid

Ferring

Preclinical

1 9

Aurlumyn

BBTG International Inc.

Preclinical

1 10

Crixivan

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Microbiota2 trials

Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity

Completed·UUniversity of Washington·Phase 4·NCT02445989·120 enrolled

Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity

Completed·UUniversity of Washington·Phase 4·NCT02432404·81 enrolled

Contraception2 trials

Psychosocial and Physiological Mechanisms in the Effect of Hormonal Contraception on the Female Sexual Desire

Completed·UUniversity Hospital, Ghent·N/A·NCT00374387·150 enrolled

Hormonal Contraception and Vaginal Health

Completed·OOregon Health and Science University·N/A·NCT00612508·14 enrolled

Menorrhagia1 trial

Efficacy of Combined Contraceptive Vaginal Ring(NuvaRing)in Women With Idiopathic Menorrhagia

Completed·MMansoura University·N/A·NCT01266759·95 enrolled

Treatment1 trial

NuvaRing vs. Oral Contraceptive Pills (OCP) for In-Vitro Fertilization (IVF) Pre-treatment

Terminated·UUniversity of Toronto·N/A·NCT01298128·70 enrolled

Adolescent1 trial

Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents

Terminated·VVirginia Commonwealth University·N/A·NCT00369967·48 enrolled

4 more indications

Acceptability1 trial

Study of Nuvaring Acceptability, Adherence and Biological Effects Among HIV-negative Women in Kenya

Completed·CCenters for Disease Control and Prevention·N/A·NCT02529683·200 enrolled

Obese1 trial

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®

Completed·—·N/A·NCT00710606·40 enrolled

Female1 trial

A Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30) (Study 34237 (P06650)) (COMPLETED)

Completed·OOrganon and Co·Phase 4·NCT01044056·24 enrolled

Ovarian1 trial

Mid-luteal Phase Synchronization of Ovarian Folliculogenesis in Women

Completed·UUniversity of Saskatchewan·N/A·NCT00565240·41 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for NuvaRing. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — NuvaRing compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for NuvaRing. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Washington company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Washington

NuvaRing

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Microbiota2 trials

Contraception2 trials

Menorrhagia1 trial

Treatment1 trial

Adolescent1 trial

Acceptability1 trial

Obese1 trial

Female1 trial

Ovarian1 trial

References

Drug Info

Quick Facts

Related News